Owain Donnelly

ORCID: 0000-0001-5813-3314
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Biosensors and Analytical Detection
  • COVID-19 Clinical Research Studies
  • SARS-CoV-2 detection and testing
  • Helminth infection and control
  • Long-Term Effects of COVID-19
  • Parasites and Host Interactions
  • Diabetes and associated disorders
  • Clinical Reasoning and Diagnostic Skills
  • Hematological disorders and diagnostics
  • Advanced biosensing and bioanalysis techniques
  • Fungal Infections and Studies
  • Blood disorders and treatments
  • Parasite Biology and Host Interactions
  • Hyperglycemia and glycemic control in critically ill and hospitalized patients
  • Malaria Research and Control
  • Viral Infections and Vectors
  • SARS-CoV-2 and COVID-19 Research
  • Inflammasome and immune disorders
  • COVID-19 epidemiological studies
  • Mosquito-borne diseases and control
  • COVID-19 diagnosis using AI

Natural History Museum
2024

The Francis Crick Institute
2024

Royal College of Surgeons in Ireland
2021

Whittington Health NHS Trust
2020

The Royal Free Hospital
2016

University College London
2016

Royal Free London NHS Foundation Trust
2015

Healthcare workers (HCWs) have a theoretically increased risk of contracting severe acute respiratory coronavirus virus 2 (SARS-CoV-2) given their occupational exposure. We tested 2,167 HCWs in London Acute Integrated Care Organisation for antibodies to SARS-CoV-2 May and June 2020 evaluate seroprevalence. found seropositivity rate 31.6% among HCWs.

10.1017/ice.2020.402 article EN cc-by Infection Control and Hospital Epidemiology 2020-08-04

Introduction: Saliva represents a less invasive alternative to nasopharyngeal swab (NPS) for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) detection. SalivaDirect is nucleic acid extraction-free method detecting SARS-CoV2 in saliva specimens. Studies evaluating the concordance of gold standard NPS and newly developed protocols are limited. The aim our study was assess as an COVID-19 testing. Methods: Matching samples were analysed from cohort symptomatic (n=127) asymptomatic...

10.12688/hrbopenres.13353.1 preprint EN cc-by HRB Open Research 2021-07-30

<ns4:p><ns4:bold>Introduction</ns4:bold>: Saliva represents a less invasive alternative to nasopharyngeal swab (NPS) for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) detection. SalivaDirect is nucleic acid extraction-free method detecting SARS-CoV2 in saliva specimens. Studies evaluating the concordance of gold standard NPS and newly developed protocols are limited. The aim our study was assess as an COVID-19 testing.</ns4:p><ns4:p> <ns4:bold>Methods</ns4:bold>: Matching...

10.12688/hrbopenres.13353.2 preprint EN cc-by HRB Open Research 2021-10-15

Abstract Background Urogenital schistosomiasis is caused by the parasitic trematode Schistosoma haematobium . Sensitive and specific point-of-care diagnostics are needed for elimination of this disease. Recombinase polymerase amplification (RPA) assays meet these criteria, an assay to diagnose S. has been developed (Sh-RPA). However, false-positive results can occur, optimisation reaction conditions mitigate needed. Ease use compatibility DNA extraction methods must also be considered....

10.1186/s13071-024-06380-9 article EN cc-by Parasites & Vectors 2024-07-28

Variant PFAPA affecting adults has been previously reported but appears to be either extremely rare or systematically underdiagnosed.

10.1186/1546-0096-13-s1-p176 article EN cc-by Pediatric Rheumatology 2015-09-28

Background: The syndrome of periodic fevers, aphthous ulceration, pharyngitis and adenitis (PFAPA) is an inflammatory disorder unknown aetiology diagnosed in children with typical clinical presentation systemic inflammation whom genetic testing for heritable fever syndromes negative.Most cases resolve by the end adolescence.PFAPA affecting adults, either as a new diagnosis or extending into adulthood, has been previously reported but appears to be extremely rare underdiagnosed.Methods: We...

10.1093/rheumatology/kew134.001 article EN Lara D. Veeken 2016-04-24
Coming Soon ...